96 reports

INFECTION, NEUROSCIENCE, AND GASTROINTESTINAL RESPIRATORY, INFLAMMATION, AND AUTOIMMUNITY In FY2014, this segment generated $##. ## billion, which was ##. ##% higher than the segment' s revenue in FY2013.

  • Allergy Drug
  • Respiratory Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.
  • GLAXOSMITHKLINE

It is involved in discovering, developing, manufacturing, and commercializing prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases globally.

  • Respiratory Disease
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • ASTRAZENECA: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014
  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

It designs manufactures, and markets endoscopy devices endoscopic video imaging systems; gastrointestinal, colon, duodenal, and broncho endoscopes, endoscopic ultrasound systems, ultrasound endoscopes and probes, ultrasound imaging systems, capsule endoscopy systems, sterilization systems m

  • Respiratory Disease
  • Boston Scientific Corporation
  • Broncus Medical Inc.
  • Medtronic, Inc.
  • Olympus Corporation
  • SAFETY OF STIOLTO RESPIMAT

THE COMPANY' S OVERALL PHARMACEUTICAL PORTFOLIO COVERS A VARIETY OF THERAPEUTIC AREAS, INCLUDING CV AND METABOLIC DISORDERS, NEUROSCIENCE, GASTROINTESTINAL DISORDERS, ONCOLOGY, RESPIRATORY, AND INFECTIOUS DISEASES.

  • Respiratory Disease
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • Key vendor analysis

gastrointestinal diseases.

  • Asthma
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.

gastrointestinal diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

gastrointestinal, and neuroscience diseases worldwide.

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pipeline Landscape Assessment
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY
  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Pharmaceutical Market, Global, Developmental
  • Asthma Therapeutics Market, Global, Co-Development Deals Valued Above $100m, 2006-2016
  • Respiratory Disease
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG

It is a global biopharmaceutical company that focuses on the following segments: respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal disorders.

  • Allergy Drug
  • Respiratory Disease
  • Forecast
  • Novartis AG
  • Sanofi S.A.
  • ASTRAZENECA REVENUE BY THERAPEUTIC SEGMENT (2013/2014)
  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, CF TREATMENT PLAN, 2016
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUE FOR ESBRIET ($BN),

As CF is a multi-system disease, even if the lung transplant is successful, pancreatic, gastrointestinal and reproductive problems will remain.

  • Respiratory Disease
  • World
  • Market Size
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • EUROPE OXYGEN THERAPY EQUIPMENT MARKET

DISEASES COVERED UNDER SUCH PROGRAMS INCLUDE MOST CARDIOVASCULAR & GASTROINTESTINAL DISORDERS, ASTHMA, BREAST CANCER, CHRONIC-OBSTRUCTIVE PULMONARY DISEASE, CORONARY HEART DISEASE & HEART FAILURE, DIABETES ETC.

  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.

gastrointestinal diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

MERGER AND ACQUISITION ASTRA ZENECA (2015) FIGURE ##: ASTRA ZENECA REVENUE BY SEGMENTS CARDIOVASCULAR & METABOLIC DISEASES ONCOLOGY RESPIRATORY, INFLAMMATION AND AUTOIMMUNITY INFECTION, NEUROSCIENCE AND GASTROINTESTINAL ##% ##% ##% ##% (2015) FIGURE ##: ASTRA ZENECA REVENUE, BY RESPIR

  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group

Discovers, develops, and commercializes prescription medicines for the cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, and inflammation AEROGEN AIRON ASTRAZENECA Description DEVILBISS HEALTHCARE BRIGGS HEALTHCARE BOEHRINGER INGELHEIM areas.

  • Respiratory Disease
  • Bespak plc
  • Consort Medical plc
  • Gerresheimer AG
  • Nypro Inc.
  • 9 Appendix

gastrointestinal, immunology and respiratory diseases Small molecules for asthma and COPD Small molecules for asthma and allergic rhinitis Small molecules for asthma and inflammation Soluble Beta glucan SPL-## Metabolab University of California Small molecule Small molecule channel protein

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG

THEY PROVIDE INNOVATIVE, EFFECTIVE PRESCRIPTION MEDICINES IN SEVERAL IMPORTANT AREAS OF MEDICAL NEED: GASTROINTESTINAL, CARDIOVASCULAR, ONCOLOGY, NEUROSCIENCE, ANESTHESIA, INFECTION, RESPIRATORY & INFLAMMATION.

  • Pharmaceutical
  • Respiratory Disease
  • China
  • Supply
  • Zhejiang Expressway Co., Ltd.
  • Target
  • Hospital
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • 9 Appendix

Gastrointestinal, Respiratory and Central Nervous System Diseases ADC-## ITP-## Pulmagen Therapeutics Tolerys Small molecule PPAR Vaccine Interleukin Small molecule to Antagonize G Protein Coupled Receptors for Respiratory Disorders JNJ-## Small molecules to Inhibit Pan Selectin for

  • Respiratory Disease
  • Asia
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc

Gastrointestinal Disease.

  • Respiratory Disease
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

The presented data includes findings from Qu Biologics' randomized, controlled trial in Crohn' s disease for their lead immunomodulatory product, QBECO, which targets the gastrointestinal tract, as well as preclinical data for QBKPN, which restores innate immune function in the lun

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

They provide innovative, effective prescription medicines in several important areas of medical need: gastrointestinal, cardiovascular, oncology, neuroscience, anesthesia, infection, respiratory & inflammation.

  • Respiratory Disease
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • GlaxoSmithKline plc
  • Zhejiang Expressway Co., Ltd.

Gastrointestinal System in Severely Ill Patients GDCT## EudraCT-2011-002093-##, Respiratory Chronic Obstructive Pulmonary Disease (COPD), Ileus (Intestinal Obstruction), Lung Infections, Other Gastrointestinal Disorders, Pancreatitis, Peritonitis, Pneumonia Completed Phase IV

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Vernalis Plc
  • Products under Development by Universities/Institutes, H1 2017
  • Cough Cold
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • Vernalis Plc
  • Products under Development by Universities/Institutes, H2 2017
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • Vernalis plc
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative
  • Pharmaxis Ltd
  • PERENNIAL ALLERGIC RHINITIS - PIPELINE BY PFIZER INC., H2 2016
  • Perennial Allergic Rhinitis - Companies Involved in Therapeutics Development

It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women' s health issues, orphan diseases and genitourina

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.
  • SEASONAL ALLERGIC RHINITIS - PIPELINE BY PFIZER INC., H2 2016

It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women' s health issues, orphan diseases and genitourina

  • Allergy Drug
  • OTC
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.